Labiana Health, S.A. (BME:LAB)
Spain · Delayed Price · Currency is EUR 5.70
-0.05 (-0.87%)
At close: Oct 6, 2026
Labiana Health Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 47 | 34 | 21 | 9 | 24 | - | |
Market Cap Growth | 56.25% | 62.46% | 134.14% | -63.32% | - | - |
Enterprise Value | 77 | 65 | 51 | 43 | 66 | - |
Last Close Price | 5.70 | 4.76 | 2.91 | 1.23 | 3.30 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.60 | 13.18 | 82.23 | - | - | - |
Forward PE | 7.32 | 8.03 | 11.72 | 18.18 | - | - |
PS Ratio | 0.62 | 0.44 | 0.31 | 0.15 | 0.40 | - |
PB Ratio | 9.94 | 7.12 | 8.12 | 2.62 | 3.51 | - |
P/TBV Ratio | 8.63 | 6.18 | 6.52 | 2.38 | 3.48 | - |
P/FCF Ratio | - | - | 4.99 | - | 12.79 | - |
P/OCF Ratio | 27.84 | 19.92 | 2.90 | - | 5.19 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.01 | 0.85 | 0.75 | 0.73 | 1.09 | - |
EV/EBITDA Ratio | 7.98 | 6.74 | 7.01 | 65.09 | 136.09 | - |
EV/EBIT Ratio | 10.62 | 8.97 | 9.94 | - | - | - |
EV/FCF Ratio | - | - | 12.10 | - | 34.75 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 7.71 | 7.71 | 13.78 | 12.26 | 5.56 | 3.95 |
Debt / EBITDA Ratio | 3.79 | 3.79 | 4.91 | 62.53 | 79.34 | 14.41 |
Debt / FCF Ratio | - | - | 8.47 | - | 20.26 | 28.24 |
Net Debt / Equity Ratio | 6.47 | 6.47 | 11.16 | 11.39 | 5.20 | 3.66 |
Net Debt / EBITDA Ratio | 3.18 | 3.18 | 3.97 | 58.09 | 74.10 | 13.37 |
Net Debt / FCF Ratio | -11.58 | -11.58 | 6.86 | -11.13 | 18.92 | 26.19 |
Asset Turnover | 1.40 | 1.40 | 1.21 | 1.00 | 0.94 | 0.89 |
Inventory Turnover | 2.82 | 2.82 | 2.47 | 2.06 | 2.09 | 1.80 |
Quick Ratio | 0.84 | 0.84 | 0.81 | 0.67 | 0.43 | 0.48 |
Current Ratio | 1.39 | 1.39 | 1.30 | 1.17 | 0.82 | 0.97 |
Return on Equity (ROE) | 69.73% | 69.73% | 6.92% | -87.09% | -98.88% | -16.35% |
Return on Assets (ROA) | 8.28% | 8.28% | 5.72% | -2.01% | -2.16% | 0.56% |
Return on Invested Capital (ROIC) | 20.43% | 21.75% | 13.86% | -4.53% | -4.62% | 1.16% |
Return on Capital Employed (ROCE) | 20.80% | 20.80% | 17.00% | -5.60% | -8.70% | 1.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.43% | 7.59% | 1.22% | -49.69% | -36.86% | - |
FCF Yield | -5.62% | -7.85% | 20.04% | -39.14% | 7.82% | - |